T1D susceptibility was subsequently mapped to a non-coding region of human CTLA-4 that resulted in lower levels of the CTLA-4 soluble splice variant; the mouse gene also demonstrated alterations in CLTA4 splicing (77). The gene discussed is CTLA4; the disease is type 1 diabetes mellitus.